These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1666451)
1. Venous thromboprophylaxis in the 1990s: a perspective. Fareed J Semin Thromb Hemost; 1991 Oct; 17(4):317-21. PubMed ID: 1666451 [No Abstract] [Full Text] [Related]
2. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives. Breyer HG Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453 [No Abstract] [Full Text] [Related]
4. Low molecular weight heparin for the prevention and treatment of venous thromboembolism. Raskob GE Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement. Eriksson BI; Kälebo P; Risberg B Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714 [No Abstract] [Full Text] [Related]
6. Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective. Caprini JA; Arcelus JI; Traverso CI; Hasty JH Semin Thromb Hemost; 1991 Oct; 17(4):356-66. PubMed ID: 1666456 [No Abstract] [Full Text] [Related]
7. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins? Agnelli G Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776 [No Abstract] [Full Text] [Related]
13. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Bergqvist D Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956 [TBL] [Abstract][Full Text] [Related]
14. When can the patient with deep venous thrombosis begin to ambulate? Aldrich D; Hunt DP Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299 [No Abstract] [Full Text] [Related]
15. [Non controlled prospective study of the efficacy and tolerance of a low molecular weight heparin]. Wattrisse G; Lecoutre D; Groux-Pante C J Mal Vasc; 1991; 16(4):367-71. PubMed ID: 1665169 [TBL] [Abstract][Full Text] [Related]
16. Prevention of thromboembolic disease in general surgery with clexane (enoxaparin). Combe S; Samama MM Semin Thromb Hemost; 1991; 17 Suppl 3():291-5. PubMed ID: 1661438 [No Abstract] [Full Text] [Related]
17. The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin. Turpie AG Br J Clin Pract Suppl; 1989 Jan; 65():18-23; discussion 23-5. PubMed ID: 2554949 [No Abstract] [Full Text] [Related]
18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
19. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial]. Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830 [No Abstract] [Full Text] [Related]
20. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin]. Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]